US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

Later this month, the Street will have a fresh opportunity to gauge the potential for Amgen's experimental weight-loss drug, MariTide.

A Mounjaro user has revealed what happened when they accidentally overdosed using the controversial 'golden dose'. ICYMI, ...

Researchers observed inequities in receipt of first-line preferred therapies among a cohort of patients with chronic ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

Buy low, sell high” is a common investing mantra. It’s easy to understand, but often hard to execute because emotion gets in ...

TD Cowen has lowered Eli Lilly’s price target from $1,050 to $960, but maintained a Buy rating, citing solid long-term ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...

The Gabelli Growth Fund (GABGX) returned (8.5)% during Q1 of 2025 vs. (10.0)% return for the Russell 1000 Growth Index. Click ...

This target price adjustment aligns with investors shifting their focus towards the third quarter results of the SURPASS-CVOT ...

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...